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In 2006, Takahashi and Yamanaka 1 reported the astonishing effect of forcing the simultaneous expression of a "cocktail" of four transcription factors (OCT4, SOX2, KLF4, and cMYC) on cells in the laboratory. This cocktail hijacked the controls and regulators that determine what a cell can or cannot do and "reverted" cells into a state very similar to that of embryonic stem cells. Embryonic stem cells are special cells that exist only briefly during the early stages of embryonic development. They are pluripotent and eventually produce all the cells that constitute the adult organism. The generation, in the laboratory, of pluripotent cells that were similar to embryonic stem cells was an awesome feat; these cells were termed induced pluripotent stem cells (iPSCs). Now we know that cells from all sources in the adult organism, when exposed to this cocktail, lose their distinguishing features, transition through an unstable undifferentiated phase, and eventually become stable iPSCs.
Scientists in the laboratory have mastered in vitro culture conditions to guide the differentiation of iPSCs into medically relevant cell types that can be used for therapeutic purposes. For example, cells from the skin of a patient who has had a myocardial infarction can be converted into iPSCs in the laboratory and then differentiated into cardiomyocytes. The hope is that these healthy cardiomyocytes could be transplanted into the infarction scar to restore, at least partially, cardiac tissue and function; data from studies in animals suggest that such an approach is feasible.
2 Another example is described by Mandai, Takahashi, Yamanaka, and colleagues 3 in this issue of the Journal: the transplantation of a sheet of retinal pigment epithelial cells, derived from iPSCs, into the macula of a woman with advanced age-related macular degeneration.
Scientists are also exploring the possibility of attempting a similar procedure directly within the damaged tissue or organ -that is, in situ reprogramming followed by differentiationwhich would avoid the manipulation of cells in the laboratory and would not require cell transplantation, a process that is generally inefficient. Expression of the four transcription factors in mice was shown to have transformative effects similar to those seen in vitro 4, 5 : a fraction of cells within tissues lose their distinctive features, become undifferentiated, and eventually convert into bona fide iPSCs. 4 The generation of iPSCs in vivo is important from an academic point of view but is not desirable for clinical applications, because iPSCs are known to produce a particular type of tumor known as a teratoma. Indeed, mice expressing the four transcription factors for a sufficiently long period (≥1 week) eventually develop multiple teratomas. 4, 5 A more interesting prospect than achieving full reprogramming in vivo is the induction of partial reprogramming (i.e., the induction of undifferentiated cells that are not yet iPSCs). After transient expression of the four transcription factors, most of the partially reprogrammed cells generated within tissues are able to redifferentiate into normal, healthy cells, fully restoring normal tissue architecture, which indicates that partially reprogrammed cells in vivo are functional. 5 Ocampo and colleagues recently reported that short bursts of partial reprogramming in vivo "rejuvenate" old tissues and extend the life span of progeric mice (Fig. 1) . 6 The authors reasoned that short pulses of the four transcription factors would partially reprogram some cells, which would acquire a progenitor-like state without being fully reprogrammed into iPSCs. Indeed, when mice were subjected to this protocol over a period of 3 weeks, the researchers could not find markers of full reprogramming, and teratomas did not develop. Old mice that were subjected to three cycles of partial reprogramming became more resistant to a subsequent tissue injury, such as the injury that typically occurs in response to cardiotoxin (which can damage myocytes) or streptozotocin (which is toxic to the beta cells of the islets of Langerhans).
Ocampo and colleagues also expressed the four transcription factors in a mouse model of the Hutchinson-Gilford progeria syndrome. These mice age prematurely and typically die at 4.5 months (the normal life span of a healthy mouse is approximately 2.5 years). Remarkably, cyclic pulses of partial reprogramming extended the life span of the progeric mice by 33%, to 6 months. 6 Multiple aging-related pathologic conditions develop in mice with this form of progeria, including skin frailty; immunodepletion; degenerative processes in the intestine, kidney, and blood vessels; and reduced heart rate. Impressively, all these defects were found to be partially ameliorated by cyclic partial reprogramming.
Although there are many questions that have yet to be answered, including questions about the long-term effects of partial reprogramming in long-lived large-animal models, the work of The tissues of young animals are characterized by a high rate of cell renewal, which is supported by a relatively high number of active progenitor cells and few damaged cells. In contrast, the tissues of older animals have low rates of cell renewal -in part because of a low number of active progenitors -and thereby accumulate damaged cells. Partial reprogramming, generated by a pulse of expression of four transcription factors (OCT4, SOX2, KLF4, and cMYC), as performed by Ocampo et al., 6 pushes some cells into an undifferentiated, plastic state in which they have progenitor properties. These progenitor-like cells renew the tissue and favor the replacement of damaged cells, thereby resulting in tissue rejuvenation. 
